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Since the introduction of the Affordable Care Act (ACA) in 2012,
11 million more Americans now have access to preventive ser-
vices via health care coverage. Several prevention-related recom-
mendations  issued by the  US Preventive  Services  Task Force
(USPSTF), Centers for Disease Control and Prevention (CDC),
and Advisory Committee on Immunization Practices (ACIP) are
covered under the ACA. State cancer plans often provide preven-
tion strategies, but whether these strategies correspond to federal
evidence-based recommendations is unclear. The objective of this
article is to assess whether federal evidence-based recommenda-
tions, including those covered under the ACA, are included in the
Maryland Comprehensive Cancer Control Plan (MCCCP).
Methods
A total of 19 federal recommendations pertaining to cancer pre-
vention and control were identified. Inclusion of federal cancer-re-
lated recommendations by USPSTF, CDC, and ACIP in the MC-
CCP’s goals, objectives, and strategies was examined.
Results
Nine of the federal recommendations were issued after the MC-
CCP’s publication. MCCCP recommendations corresponded com-
pletely with 4 federal recommendations and corresponded only
partially with 3. Reasons for partial correspondence included spe-
cification of less restrictive at-risk populations or different inter-
vention implementers. Three federal recommendations were not
mentioned in the MCCCP’s goals, objectives, and strategies.
Conclusion
Many cancer-related federal recommendations were released after
the MCCCP’s publication and therefore do not appear in the most
current version. We recommend that the results of this analysis be
considered in the update of the MCCCP. Our findings underscore
the need for a periodic scan for changes to federal recommenda-
tions and for adjusting state policies and programs to correspond
with federal recommendations, as appropriate for Marylanders.
Introduction
The Centers for Disease Control and Prevention (CDC) funds all
50 states through the National Comprehensive Cancer Control
Program (NCCCP) to develop and implement comprehensive can-
cer control plans (1). There is no standard national cancer plan; in-
stead, state cancer plans vary on the basis of content and organiza-
tion, depending on a host of factors including state priorities, polit-
ical climate, and stakeholder involvement and partnership. Fur-
thermore, cancer plans are not static but are updated and revised
on an ongoing basis. For example, Maryland revises its plan every
3 to 5 years (2). According to CDC, one goal of comprehensive
cancer control planning is to disseminate and implement best prac-
tices and evidence-based strategies (1). The US Preventive Ser-
vices Task Force (USPSTF), CDC, and Advisory Committee on
Immunization Practices (ACIP) all issue cancer-related evidence-
based recommendations (3–5). USPSTF’s grade A and B recom-
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mendations and many of CDC’s and ACIP’s recommendations
and guidelines are covered under the Affordable Care Act (ACA)
(3–5). To our knowledge, there has not been an assessment of any
state cancer plan examining the extent to which these recommend-
ations are included.
The first Maryland cancer plan was written in 1991 and has been
updated several times since. The most recent plan, published in
2011, was developed by more than 200 contributors including rep-
resentatives from hospitals, academia, nongovernmental organiza-
tions, and government, as well as citizens. Contributors formed
committees to write specific chapters in the Maryland Compre-
hensive Cancer Control Plan (MCCCP). The process included an
extensive review of evidence-based recommendations from mul-
tiple sources that were published when the plan was being de-
veloped. Recommendations from reputable sources such as USP-
STF, CDC, the American Cancer Society, and many others relev-
ant to the specific topic area were reviewed and considered by the
MCCCP contributors. In addition, other recently published Mary-
land health plans were reviewed to achieve a cohesive approach to
the development of goals, objectives, and strategies. MCCCP con-
tributors used these recommendations, Maryland-specific data,
and the expertise of many local physicians, academicians, public
health practitioners, community health workers, cancer survivors,
and others to determine the final goals, objectives, and strategies
to be included in the MCCCP.
The 15-chapter plan focuses on primary, secondary, and tertiary
cancer prevention and control and includes cross-cutting surveil-
lance and health disparities sections. Priorities for overcoming the
issues described in the MCCCP are presented at the end of each
chapter in the form of goals, objectives, and strategies (2), all of
which are actionable activities that can be implemented by profes-
sionals working in the field of cancer prevention and control.
The purpose of this investigation was to compare the goals, object-
ives, and strategies in the Maryland Comprehensive Cancer Con-
trol Plan (MCCCP) (2) with the cancer-related, evidence-based re-
commendations of federal  agencies that  are covered under the
ACA. We examined the extent to which cancer-related USPSTF
recommendations (grade A and B only), ACIP recommendations,
and CDC guidelines were included in the 2011 MCCCP’s goals,
objectives, and strategies. The goal of this assessment is to inform
future updates of the MCCCP and to provide a model for other
state cancer plans.
Methods
We reviewed recommendations issued by the USPSTF, ACIP, and
CDC. The rationale for using these authoritative bodies was their
extensive reliance on evidence-based medicine in addition to their
cancer-related recommendations covered under  the ACA. The
Agency for Healthcare Research and Quality (6) and the National
Cancer Institute (7) websites refer to USPSTF recommendations,
which supports our selection of the USPSTF. USPSTF and ACIP
recommendations and CDC guidelines are updated periodically.
Nineteen cancer prevention and control-related recommendations
or guidelines released by May 31, 2014 were included in our as-
sessment (Table).
For  this  analysis,  we  selected  federal  recommendations  or
guidelines pertaining to cancer prevention and control for adults.
Because tobacco use, physical inactivity, obesity, and alcohol mis-
use increase the risk of developing cancer (8,9), we included in
our analysis recommendations and guidelines pertaining to these
behaviors and conditions. We identified 16 USPSTF recommenda-
tions (3) concerning breastfeeding, dietary counseling, risk reduc-
tion and genetic screening for women at high risk for breast can-
cer, early cancer detection screening, obesity, tobacco use cessa-
tion, diet, alcohol use, sun exposure, and hepatitis B virus (HBV)
and hepatitis C virus (HCV) screening. In addition, we identified
one ACIP recommendation (5) that did not correspond to the USP-
STF recommendation pertaining to human papillomavirus (HPV)
vaccination. From CDC guidelines (4), one physical activity and
one healthy alcohol use guideline was identified. There was com-
plete  overlap  between  the  USPSTF and  ACIP recommending
screening for HBV infection in pregnant women and in adults at
high risk. Both the USPSTF and ACIP recommend that “all preg-
nant women should be tested routinely for HBsAg during an early
prenatal visit” and that “all adults at risk for HBV infection be
screened” (HbsAg is an HBV surface antigen). We used the USP-
STF recommendations, because they were rated as grade A (test-
ing for surface antigens in pregnant women) and grade B (testing
for surface antigens in high-risk adults). Additionally, the USP-
STF 2002 (as opposed to the 2009) mammography recommenda-
tion was adopted by the ACA and is the one included in this as-
sessment.
If a federal recommendation or guideline was issued after the re-
lease of the MCCCP (July 2011), it was classified as “MCCCP
published prior to recommendation.” If the MCCCP was released
after the federal recommendation was issued, it was classified as
“complete correspondence” if the MCCCP met 3 specific criteria:
the goal, objective, and strategies had to 1) recommend the same
implementer as the federal recommendation or guideline, 2) re-
commend the same intervention as the federal recommendation or
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guideline, and 3) direct the implementation to the same target pop-
ulation as the federal recommendation or guideline. If an MCCCP
strategy met at least one but not all of these criteria, it was classi-
fied as “partial correspondence.” If a federal recommendation or
guideline was issued before the 2011 MCCCP but did not appear
in the MCCCP’s goals, objectives, and strategies, it was classified
as “no mention.”
Results
We identified 19 federal recommendations and guidelines pertain-
ing to primary and secondary cancer prevention and control for
adults (Table). Nine recommendations, all from the USPSTF, were
issued after the release of the MCCCP in July 2011 (47.4%). Of
the remaining 10, complete correspondence was found for 4 re-
commendations (21.1%) in the domains of breast feeding, early
detection screening, vaccinations, and physical activity. There was
partial  correspondence for  3  recommendations  and guidelines
(15.8%). Reasons for partial correspondence stemmed from the
MCCCP strategy having less restrictive at-risk populations (eg,
screening age for colorectal cancer ending at 75 [USPSTF] vs no
age limit [MCCCP], n = 1) and from having specified alternate in-
tervention implementers (eg, physicians [USPSTF] vs hospitals
[MCCCP] engaged in smoking cessation, n = 2). Three of the fed-
eral recommendations or guidelines were in place at the time of
the  MCCCP’s  publication  but  were  not  mentioned  in  the
MCCCP’s goals, objectives, and strategies (15.8%).
Discussion
We assessed the extent to which selected federal evidence-based
recommendations covered under the ACA were included in the
current MCCCP. The MCCCP did not include many of the feder-
al recommendations considered by this study or had partial corres-
pondence. The MCCCP is updated every 5 years, so although it is
intended to be current and inclusive, the 2011 MCCCP predated
the issuance of many of the federal recommendations. Reasons for
partial  correspondence stemmed from selected federal  recom-
mendations differing from other authoritative sources consulted
during the development of the MCCCP, such as the American
Cancer Society and the American Congress of Obstetricians and
Gynecologists. Because the MCCCP predated the introduction of
the ACA, the current assessment approach could not have been
used to select strategies during the development of the current
MCCCP. However, going forward, such an assessment could be
used to update the MCCCP and other state cancer plans. Below we
discuss how to ensure that recommendations covered by the ACA
are included in the updated MCCCP.
MCCCP published before recommendations
Of the 19 federal  recommendations or guidelines identified,  9
were issued after the MCCCP was released in July 2011. USPSTF
and ACIP recommendations and CDC guidelines are revised as
the scientific evidence base is refined; the timing of those revi-
sions and additions do not necessarily align with the 5-year cycles
of the MCCCP. Full revision of the MCCCP is a massive under-
taking by hundreds of contributors resulting in a consensus docu-
ment. Therefore, wholesale revision of the MCCCP each time a re-
commendation is revised or added may not be feasible. Hence, in-
cluding links to sources of up-to-date recommendations in the
MCCCP  and  providing  access  to  updated  recommendations
through addendums released online between the more compre-
hensive revisions that occur every 5 years is recommended. The
Center for Cancer Prevention and Control (CCPC) in the Cancer
and  Chronic  Disease  Bureau  of  the  Maryland  Department  of
Health and Mental Hygiene (DHMH) uses this practice to keep the
MCCCP current between the 5-year cycles.
No mention in goals, objectives, and strategies
Three of the national recommendations were in place before July
2011 but were not included in the MCCCP’s goals, objectives, and
strategies. The site-specific chapters of the MCCCP focus on 7
cancers that are targeted by the state’s Cigarette Restitution Fund
(CRF) Program (breast, cervical, colorectal, lung, melanoma, oral,
and prostate), which were selected in 2000 as priorities because of
their high burden in the state, modifiable risk factors, or effective
early detection methods. One of the 3 recommendations not in-
cluded addresses HBV, a risk factor for liver cancer (10). Since
liver cancer is not one of the CRF-targeted cancers, MCCCP au-
thors decided to address liver cancer only in the disparities chapter
and  not  in  its  own  chapter  or  in  the  goals,  objectives,  and
strategies of the current MCCCP. To keep the MCCCP current, it
may be advisable to broaden the scope of future versions of the
plan to include additional cancer prevention recommendations that
address cancer sites beyond the CRF-targeted cancers.
In addition, alcohol misuse, an important modifiable risk factor
that contributes to risk of cancer, was not mentioned in the goals,
objects, and strategies. The CCPC is “responsible for assessing
cancer control in Maryland and developing cancer control priorit-
ies through collaboration with the State Council on Cancer Con-
trol and other state agencies” (11) and develops and periodically
updates the MCCCP. Although other arms within the DHMH co-
ordinate programs and implement primary and secondary cancer
prevention and control-related interventions (eg, DHMH Infec-
tious Disease Bureau), alcohol misuse is handled by the Alcohol
and Drug Abuse Administration, an arm of the DHMH that did not
contribute to the 2011 MCCCP. As a means of facilitating the use
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of the assessment used in current study for updating future cancer
plans, participation from this and other relevant DHMH adminis-
trations and centers is recommended.
Partial correspondence between the MCCCP and
national recommendations and guidelines
Three of the federal recommendations and guidelines were in-
cluded  in  the  MCCCP,  but  they  differed  on  either  the  imple-
menter or the targeted population.
Different implementer. Two recommendations and guidelines had
partial correspondence because the recommended implementer of
the interventions differed. Specifically, in 2 cases the MCCCP
identified the hospital as the implementer whereas the federal re-
commendation specified the physician as the implementer of the
intervention. Although physician groups did participate in the de-
velopment of the MCCCP, this highlights the importance of soli-
citing a more direct and central role in the writing and implement-
ation of the plan’s goals, objectives, and strategies.
Less restrictive at-risk population in the MCCCP. Another reason
for partial correspondence occurred with the specifics of screen-
ing  recommendations,  primarily  the  relevant  age  groups  for
screening. Although our assessment was limited to USPSTF and
CDC recommendations and CDC guidelines, the MCCCP refers to
additional  national  recommendations  throughout,  including
screening recommendations set by the American Cancer Society,
the American College of Gastroenterology, the American Dental
Association,  and the  American Congress  of  Obstetricians  and
Gynecologists. In addition, the Maryland DHMH convenes state
medical advisory groups to address various screening guidelines,
including those provided by USPSTF; these recommendations are
used in the implementation of the Cancer Prevention, Education,
Screening and Treatment Program for the uninsured and under-
insured. It may be possible to harmonize payment guidelines with
the ACA and MCCCP recommendations. In light of additional na-
tional health quality and cost guidelines and life expectancy calcu-
lations (12,13), revisiting these recommendations may also be in
order.
This assessment assumed that all current cancer-related USPSTF,
ACIP, and CDC evidence-based recommendations should be in-
cluded in state comprehensive cancer control plans. Comparison
of the MCCCP’s goals, objectives, and strategies with the selec-
ted federal recommendations highlighted the degree of corres-
pondence with the MCCCP, which is the most comprehensive and
inclusive cancer plan to date for Maryland. Of the 5 state plans
published since 1991, this plan had the most contributors, had the
greatest sector representation, and addressed individual, system,
and environment concerns. To help maximize health care cover-
age and access to preventive services, we recommend using this
assessment as part of the planning process for future updates of the
MCCCP. Incorporating up-to-date evidence-based recommenda-
tions, in particular those covered by the ACA, into MCCCP goals,
objectives, and strategies is crucial for encouraging state cancer
plan users to close the gaps in coverage of these important ser-
vices. The first step in enabling plan users to implement evidence-
based objectives and strategies proven effective at reducing the in-
cidence and burden of cancer is to first incorporate them into the
plan. Therefore, comprehensive cancer control plans should be
evidence-based to help guide development of statewide priorities
that are reflective of the state’s burden to inform implementation
strategies and to evaluate impact. In addition to providing import-
ant cancer plan funding, another role of CDC in keeping plans up
to date would be to support state research priorities through its
partnerships with academic institutions and care delivery organiza-
tions as a means of informing evolving priorities and generating
new evidence.
Updates of the MCCCP may also benefit from the ongoing consid-
eration of recommendations from the Task Force on Community
Preventive Services (14), which provides evidence-based recom-
mendations for community-level activities and behaviors, and the
expert opinion-based National Comprehensive Cancer Network
(15). The main impetus for including the current set of criteria in
our assessment was that these interventions are covered under the
ACA and would, thus, enhance health (16) and increase access to
preventive services  for  virtually  all  Marylanders.  Other  states
could assess their plans in a similar manner to the methods de-
scribed here to optimize population uptake and availability of pre-
ventive services (17) that are both evidence-based and cost saving
(18).
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Table
Table. Correspondence Between 19 Federal Evidence-Based Recommendations and Guidelinesa for Primary and Second-
ary Cancer Prevention and Control and Recommendations in the 2011 Maryland Comprehensive Cancer Control Plan
(MCCCP)
MCCCP Published Before Recommendations
Clinicians provide counseling about minimizing exposure to ultraviolet radiation to reduce risk for skin cancer, aged 10 to 24 years
with fair skin. (USPSTF Grade B; issued May 2012)
Screening all adults for obesity. Clinicians should offer or refer patients with a body mass index (BMI) of 30 kg/m2 or higher to
intensive, multicomponent behavioral interventions. (USPSTF Grade B; issued June 2012)
Annual screening for lung cancer with low-dose computed tomography in adults aged 55 to 80 years who have a 30 pack-year
smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not
smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative
lung surgery. (USPSTF Grade B; issued December 2013)
Primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with one of several
screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in
breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive screening results should receive genetic counseling and, if
indicated after counseling, BRCA testing. (USPSTF Grade B; issued December 2013)
Clinicians engage in shared, informed decision-making with women who are at increased risk for breast cancer about medications to
reduce their risk. For women who are at increased risk for breast cancer and at low risk for adverse medication effects, clinicians
should offer to prescribe risk-reducing medications, such as tamoxifen or raloxifene. (USPSTF Grade B; issued September 2013)
Screening for cervical cancer in women aged 21 to 65 years with cytology (Pap smear) every 3 years or, for women aged 30 to 65
years who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing
every 5 years. (USPSTF Grade A; issued March 2012)
Screening for hepatitis C virus (HCV) infection in persons at high risk for infection. Recommended one-time screening for HCV infection
to adults born between 1945 and 1965. (USPSTF Grade B; issued June 2013)
Screening for hepatitis B virus (HBV) infection in persons at high risk for infection. (USPSTF Grade B; issued May 2014)
Clinicians screen adults aged 18 years or older for alcohol misuse and provide persons engaged in risky or hazardous drinking with
brief behavioral counseling interventions to reduce alcohol misuse. (USPSTF Grade B; issued May 2013)
Complete Correspondence
Promote and support breastfeeding. (USPSTF Grade B; issued October 2008)
Screening mammography for women, with or without clinical breast examination, every 1 to 2 years for women age 40 years or older.
(USPSTF Grade B; issued September, 2002)
Proper levels of physical activity: 2 hours and 30 minutes (150 min) of moderate-intensity aerobic activity (ie, brisk walking) every
week and weight training muscle-strengthening activities on 2 or more days a week that work all major muscle groups (legs, hips,
back, abdomen, chest, shoulders, and arms).
OR
1 Hour and 15 minutes (75 min) of vigorous-intensity aerobic activity (ie, jogging or running) every week and weight training muscle-
strengthening activities on 2 or more days per week that work all major muscle groups (legs, hips, back, abdomen, chest, shoulders,
and arms).
OR
An equivalent mix of moderate- and vigorous-intensity aerobic activity and weight training muscle-strengthening activities on 2 or more
days per week that work all major muscle groups (legs, hips, back, abdomen, chest, shoulders, and arms). (CDC; issued in 2008)
Routine vaccination of HPV2 and HPV4 of females aged 11 or 12 years, and catch-up vaccination for females aged 13 through 26
Abbreviations: ACIP, Advisory Committee on Immunization Practices; ACS, American Cancer Society; CDC, Centers for Disease Control and Prevention;
Pap, Papanicolaou; USPSTF, US Preventive Services Task Force.
a Federal primary and secondary cancer prevention and control recommendations and guidelines from the USPSTF (3), CDC (4), and ACIP (5).
b MCCCP does not include specific age range, but refers to “guideline-eligible” populations.
c Explanation for MCCCP classification.
d USPSTF recommendation is specific to people with risk factors for cardiovascular disease.
e Appears in MCCCP text but not in the goals, objectives, and strategies.
(continued on next page)
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(continued)
Table. Correspondence Between 19 Federal Evidence-Based Recommendations and Guidelinesa for Primary and Second-
ary Cancer Prevention and Control and Recommendations in the 2011 Maryland Comprehensive Cancer Control Plan
(MCCCP)
MCCCP Published Before Recommendations
yearsb. (ACIP; issued March 2007)
Partial Correspondence: Less Restrictive At-Risk Population in MCCCP
Screening for colorectal cancer using fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy, in adults, beginning at age 50
years and continuing until age 75 years. (USPSTF Grade A; issued October 2008)
MCCCP recommends screening for those 50 or older per ACS/Multi-Society Taskforce guidelinesc.
Partial Correspondence: Different Implementer
Clinicians ask all adults about tobacco use and provide tobacco cessation interventions for those who use tobacco products. (USPSTF
Grade A; issued April 2009)
MCCCP states hospitals should adopt inpatient counseling and treatment of tobacco-using patientsc.
Clinicians ask all pregnant women about tobacco use and provide augmented pregnancy-tailored counseling to those who smoke.
(USPSTF Grade A; issued April 2009)
MCCCP states hospitals should adopt inpatient counseling and treatment of tobacco-using patientsc.
No Mention in Goals, Objectives, and Strategies
Screening for HBV infection in pregnant women at their first prenatal visit. (USPSTF Grade A; issued June 2009)
Intensive behavioral dietary counseling . . . diet-related chronic disease. Intensive counseling can be delivered by primary care
clinicians or by referral to other specialists, such as nutritionists or dietitiansd. (USPSTF Grade B; issued January 2003)
According to the Dietary Guidelines for Americans, moderate alcohol consumption is defined as having up to 1 drink per day for
women and up to 2 drinks per day for mene. (CDC; issued in 2010)
Abbreviations: ACIP, Advisory Committee on Immunization Practices; ACS, American Cancer Society; CDC, Centers for Disease Control and Prevention;
Pap, Papanicolaou; USPSTF, US Preventive Services Task Force.
a Federal primary and secondary cancer prevention and control recommendations and guidelines from the USPSTF (3), CDC (4), and ACIP (5).
b MCCCP does not include specific age range, but refers to “guideline-eligible” populations.
c Explanation for MCCCP classification.
d USPSTF recommendation is specific to people with risk factors for cardiovascular disease.
e Appears in MCCCP text but not in the goals, objectives, and strategies.
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